Identification and Characterization of the Structural and Transporter Genes for, and the Chemical and Biological Properties of, Sublancin 168, a Novel Lantibiotic Produced by Bacillus subtilis 168*

An antimicrobial peptide produced byBacillus subtilis 168 was isolated and characterized. It was named sublancin 168, and its behavior during Edman sequence analysis and its NMR spectrum suggested that sublancin is a dehydroalanine-containing lantibiotic. A hybridization probe based on the peptide sequence was used to clone the presublancin gene, which encoded a 56-residue polypeptide consisting of a 19-residue leader segment and a 37-residue mature segment. The mature segment contained one serine, one threonine, and five cysteine residues. Alkylation of mature sublancin showed no free sulfhydryl groups, suggesting that one sulfydryl had formed a β-methyllanthionine bridge with a dehydrobutyrine derived by posttranslational modification of threonine; with the other four cysteines forming two disulfide bridges. It is unprecedented for a lantibiotic to contain a disulfide bridge. The sublancin leader was similar to known type AII lantibiotics, containing a double-glycine motif that is typically recognized by dual-function transporters. A protein encoded immediately downstream from the sublancin gene possessed features of a dual-function ABC transporter with a proteolytic domain and an ATP-binding domain. The antimicrobial activity spectrum of sublancin was like other lantibiotics, inhibiting Gram-positive bacteria but not Gram-negative bacteria; and like the lantibiotics nisin and subtilin in its ability to inhibit both bacterial spore outgrowth and vegetative growth. Sublancin is an extraordinarily stable lantibiotic, showing no degradation or inactivation after being stored in aqueous solution at room temperature for 2 years. The fact that sublancin is a natural product of B. subtilis 168, for which a great deal of genetic information is available, including the entire sequence of its genome, suggests that sublancin will be an especially good model for studying the potential of lantibiotics as sources of novel biomaterials.

[1]  P. Carthew,et al.  Synthesis and PMR properties of some dehydroalanine derivatives , 1972 .

[2]  J. Hansen,et al.  The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms , 1993, Applied and environmental microbiology.

[3]  L. Lian,et al.  A novel post-translational modification of the peptide antibiotic subtilin: isolation and characterization of a natural variant from Bacillus subtilis A.T.C.C. 6633. , 1993, The Biochemical journal.

[4]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[5]  S. Stevanović,et al.  Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin , 1992, Journal of bacteriology.

[6]  M. Gasson,et al.  Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5 , 1996, Applied and environmental microbiology.

[7]  J. Hansen,et al.  Some chemical and physical properties of nisin, a small-protein antibiotic produced by Lactococcus lactis , 1990, Applied and environmental microbiology.

[8]  D. Diep,et al.  A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export , 1995, Molecular microbiology.

[9]  R. Lathe.  Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. , 1985, Journal of molecular biology.

[10]  A. Goffeau,et al.  The complete genome sequence of the Gram-positive bacterium Bacillus subtilis , 1997, Nature.

[11]  The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme , 1985 .

[12]  B. Eisermann,et al.  Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. , 1994, Analytical biochemistry.

[13]  A. Jones,et al.  The formation of dehydroalanine residues in alkali-treated insulin and oxidized glutathione. A nuclear-magnetic-resonance study. , 1983, The Biochemical journal.

[14]  W. M. Vos,et al.  Maturation pathway of nisin and other lantibiotics: post‐translationally modified antimicrobial peptides exported by Gram‐positive bacteria , 1995, Molecular microbiology.

[15]  S. Banerjee,et al.  Structure and expression of a gene encoding the precursor of subtilin, a small protein antibiotic. , 1988, The Journal of biological chemistry.

[16]  H. Sahl,et al.  Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation , 1995 .

[17]  J. Hansen,et al.  Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. , 1992, The Journal of biological chemistry.

[18]  J. Hansen,et al.  Antibiotics synthesized by posttranslational modification. , 1993, Annual review of microbiology.

[19]  D Court,et al.  Regulatory sequences involved in the promotion and termination of RNA transcription. , 1979, Annual review of genetics.

[20]  M. Kozak.  Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. , 1983, Microbiological reviews.

[21]  J. Hansen,et al.  Conversion of Bacillus subtilis 168 to a subtilin producer by competence transformation , 1991, Journal of bacteriology.

[22]  H. Halvorson,et al.  Kinetics of Germination of Bacillus Spores , 1965, Journal of bacteriology.

[23]  H. Sahl,et al.  Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. , 1995, European journal of biochemistry.

[24]  J. Hansen,et al.  Role of the Leader and Structural Regions of Prelantibiotic Peptides as Assessed by Expressing Nisin-Subtilin Chimeras in Bacillus subtilis 168, and Characterization of their Physical, Chemical, and Antimicrobial Properties (*) , 1995, The Journal of Biological Chemistry.

[25]  J. Hansen,et al.  Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. , 1984, The Journal of biological chemistry.

[26]  S. Banerjee,et al.  Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic. , 1988, The Journal of biological chemistry.